Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (351-360 of 378) with videos related to

Pageof 38
Sort By:
Antimicrobial Agents and Chemotherapy|July 25, 2025
Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole"Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Nature Communications|July 17, 2021
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2024
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazoleRachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Lancet (London, England)|August 7, 2017
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trialCharlotte E Coles, Clare L Griffin, Anna M Kirby, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
JAMA|May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical TrialPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
The Pediatric Infectious Disease Journal|April 26, 2021
Antibiotic Safety and Effectiveness in Premature Infants With Complicated Intraabdominal InfectionsMichael J Smith, Angelique Boutzoukas, Julie Autmizguine, et al.
Pageof 38

Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Antimicrobial Agents and Chemotherapy|July 25, 2025
Erratum for Randell et al., "Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazole"Rachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Nature Communications|July 17, 2021
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNABelinda Kingston, Rosalind J Cutts, Hannah Bye, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2024
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazoleRachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Lancet (London, England)|August 7, 2017
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trialCharlotte E Coles, Clare L Griffin, Anna M Kirby, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
JAMA|May 24, 2022
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical TrialPamela J Goodwin, Bingshu E Chen, Karen A Gelmon, et al.
Lancet (London, England)|March 22, 2008
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, S M Bentzen, R K Agrawal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2022
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancerN C Turner, C Swift, B Jenkins, et al.
The Pediatric Infectious Disease Journal|April 26, 2021
Antibiotic Safety and Effectiveness in Premature Infants With Complicated Intraabdominal InfectionsMichael J Smith, Angelique Boutzoukas, Julie Autmizguine, et al.
Pageof 38